Author: sf-admin

Nes-Ziona, Israel, June 22, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today provided an update on its RAIN token holdings. As of June 20, 2026, the Company held 79,568,550,005 RAIN tokens with a total value of approximately $1.14 billion¹.

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial results for the fiscal quarter ended May 31, 2026, on Tuesday July 7, 2026, after market close. A conference call to discuss the financial results will be held on Wednesday July 8, 2026. Details for the conference call are provided below.

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to submit a New Drug Application (NDA) for EB613

MITOLINE^®-Enabled 3D Structural Modeling and Boltz AI Capabilities to Be Combined by MitoCareX in a Synergistic Virtual Screening Campaign for selected Transporter Targets

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of treatment for all participants in Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of Alcohol Use Disorder (AUD).

Atlanta, Ga., June 22, 2026 (GLOBE NEWSWIRE) — Outdoor Holding Company (Nasdaq: POWW, POWWP) (“OHC,” “we,” “us,” “our” or the “Company”), the owner of GunBroker.com, the largest online marketplace dedicated to firearms, hunting, shooting, and related products, today reported its financial results for its fourth fiscal quarter and year ended March 31, 2026.

Expected Closing Set for Q3/2026

Expected Closing Set for Q3/2026

Kandi’s International Off-Road Vehicle Business Reaches Customers in 35 Countries and Regions, Expanding in Africa, Southeast Asia, Latin America and the Middle East Alongside Robust Momentum in the North American Market

Two eBee VISION and three eBee TAC drones to support advanced ISR, tactical mapping, and operational readiness in the region

Limited ticket inventory remaining

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) — Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs. and DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced a collaboration between DiamiR and AlzLabs Precision Diagnostics (“AlzLabs”) to generate protein and microRNA blood-based biomarker data with the focus on Alzheimer’s disease.

Sydney, New South Wales, AUSTRALIA, June 22, 2026 (GLOBE NEWSWIRE) —

Australian Pokie Hub has published an informational overview discussing upcoming pokie releases and emerging trends in online slot game development. The announcement outlines gameplay innovations, design trends, and features that players may encounter in future titles from established game studios.

The U.S. Medical Affairs Outsourcing Market is projected to grow from USD 0.64 Billion in 2025 to USD 1.06 Billion by 2035, while Europe is expected to expand from USD 0.67 Billion to USD 2.41 Billion, supported by increasing clinical trial complexity, regulatory requirements, and pharmacovigilance outsourcing demand.

The U.S. Medical Affairs Outsourcing Market is projected to grow from USD 0.64 Billion in 2025 to USD 1.06 Billion by 2035, while Europe is expected to expand from USD 0.67 Billion to USD 2.41 Billion, supported by increasing clinical trial complexity, regulatory requirements, and pharmacovigilance outsourcing demand.

8.3

Vancouver, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company“), a seabed mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, today welcomed the G7 leaders’ declaration on securing supply chains for critical minerals, which underscores the strategic importance of diversified, transparent, and resilient critical minerals supply chains.

Capitol Hill Meetings with Rep. McCormick and Senior Officials | Pentagon City Defense Conference | Connecticut Facility Purchase Agreement in Progress | Strong Financial Position

Capitol Hill Meetings with Rep. McCormick and Senior Officials | Pentagon City Defense Conference | Connecticut Facility Purchase Agreement in Progress | Strong Financial Position

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026.

SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.

SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.